• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDG PET/CT Predicts Stem Cell Transplant Response in Lymphoma


Lesions detected by FDG PET/CT can predict success of stem cell transplant in patients with aggressive lymphoma.

Imaging with FDG PET/CT among patients with aggressive lymphoma can help predict response to stem cell transplant, according to a study published in Radiology.

Researchers from Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College in New York, NY, performed a retrospective review study to determine the prognostic value of performing FDG PET/CT before allogeneic and autologous stem cell transplantation (SCT) in patients with aggressive lymphoma.

One-hundred-seventy-five patients with aggressive lymphoma who underwent allogeneic or autologous SCT between January 2005 and December 2010 participated in the study. The FDG PET/CT imaging of between mid-skull and upper thigh was performed within the three-month period before the transplantation; 73 patients underwent FDG PET/CT before [[{"type":"media","view_mode":"media_crop","fid":"44068","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_90076324399","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4904","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 120px; width: 160px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]allogeneic SCT and 102 patients underwent FDG PET/CT before autologous SCT. The researchers evaluated the PET/CT images for lesions with FDG avidity greater than that of the background liver.

The results showed that before allogeneic SCT, 23 of 73 patients (32%) had FDG-avid lesions, and before autologous SCT, 11 of 102 patients (11%) had FDG-avid lesions.

Two-year progression-free survival:

Patients without FDG-avid lesions
Patients with FDG-avid lesions
Allogeneic SCT
Autologous SCT

“Similar differences were seen in overall survival and disease-specific survival,” the authors wrote. “The risk for post-transplantation recurrence correlated with higher lesional maximum standardized uptake values: for PFS, P < .0001 to P = .01; for DSS, P < .0001 to P = .002; and for OS, P < .0001 to P = .015.”

The researchers concluded that  performing FDG PET/CT before SCT in patients with aggressive lymphoma has prognostic value and gives physicians a better indication of the likelihood of SCT success.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.